Cardio-Immunologist, Macrophages. Associate Prof, Univ of Toronto. UHN. Research Director Peter Munk Cardiac Center. Loretta Rogers Chair. #Cardioimmunology
PFAS are a group of more than 14,000 compounds that manufacturers began using in the 1940s. They’re designed to be strong and long-lasting thanks to their carbon-fluorine chemical bonds.
These chemicals were created with good intentions — to keep people safe, offer convenience, and toughen up products to resist heat, oil, stains, grease and water.
We interact with forever chemicals through a long list of everyday products, including:
Nonstick cookware
Waterproof clothing
Cosmetics and personal care products
Food packaging
Stain-resistant carpets, rugs and furniture
Collected data suggests that forever chemicals can bring harmful health effects. But how much these environmental toxins impact your health varies depending on:
-How much and how often you’re exposed
-Your age, sex, ethnicity, health and genetics
Nothing in medicine ever happens by itself. Exposure to these chemicals is probably not the only reason you develop a chronic disease, but it can contribute.
You may be exposed to forever chemicals when you:
-Use products that contain PFAS
-Eat food packaged in PFAS-treated material
-Drink contaminated water
-Eat fish from contaminated water
-Eat food grown near factories making or using PFAS
-Use cosmetics and healthcare products packaged in PFAS-treated containers
Repeated or high exposure to PFAS chemicals can cause them to build up in your blood. Today, nearly all people in the U.S. have a detectable level of PFAS in their blood. High levels may lead to health issues such as:
-Increased cancer risk
-Slowed development in children
-Reduced immune function
-Reproductive challenges
-Thyroid issues
Heart failure doesn’t only affect the heart. 🫀🧠
New in JACC: Advances - people with heart failure in Ontario had a higher risk of dementia, with frailty and past stroke as key predictors.
Congrats to Paul Tieu, Dr. Douglas Lee & the UNEARTH CVD team!
jacc.org/doi/10.1016/j.jacad…
Discovery of a liver-heart axis.
Prior liver injury-> heart attack risk
How the immune system transmits inter-organ impact
cell.com/cell-metabolism/ful…
Our new paper, “Simply Aging,” is out in @PNASNews!
What is aging, when does it begin, how do we measure it, and what would it take to extend lifespan? We tackle these questions directly and simply.
📄 Read: pnas.org/doi/10.1073/pnas.26…
💬 Discuss: simplyaging.xyz/
There still in no approved or highly effective treatment for postural orthostatic tachycardia syndrome (POTS), which can be debilitating.
Now there's hope with very encouraging results of a Phase 2 randomized trial: an antibody vs natriuretic peptide receptor 1 (NRP-1)
firstwordpharma.com/story/84…
ClinicalAge, an AI-derived metric from longitudinal electronic health records, varies widely from an individual's chronological age. And it's correlated with risk of many diseases and cancers, as shown below, from 2 huge cohorts @uk_biobank@LancetDigitalHthelancet.com/journals/landi…
Love this! Amazing breakthrough and it is not an LLM (finally!) 😅🔥
Someone just made k-means 10x faster with no new hyperparameters, shipped in FAISS, works on CPU and GPU.
A 70-year-old algorithm, rebuilt with modern optimization!
Introducing e-means, an algorithm beating k-means in 10x fewer epochs.
With order of magnitude wall-clock speedups, e-means is released in FAISS and needs no hyperparameter tuning beyond k. It is robust to various scales and datasets. Still skeptical ? Just try e-means [1/10]🧵
UMAP 0.6 is out! A new initialization, new optimizers and faster nearest neighbour search make UMAP much faster and far better at large scale. On 3 million arXiv papers it finishes in under 5 minutes, before UMAP 0.5 has even found its nearest neighbours.
Getting it wrong for many decades.
Since the 1950's, pacemaker leads have been placed in the right ventricle. A new randomized trial challenging that dogma found marked superiority of outcomes for pacing from the left bundle branch. nejm.org/doi/full/10.1056/NE…
A study on accelerated aging with chemotherapy for breast cancer
More aggressive chemo, improved breast cancer survival but a tradeoff of accelerated biological aging and increased risk of non-breast cancer mortality
jamanetwork.com/journals/jam…